IUPAC Name: 1-[(2,6-Difluorophenyl)methyl]triazole-4-carboxamide 
Following is the structure of 1H-1,2,3-Triazole-4-carboxamide,1-[(2,6-difluorophenyl)methyl]- (CAS NO.106308-44-5):
                      
Empirical Formula: C₁₀H₈F₂N₄O
Molecular Weight: 238.1935 g/mol
Molar Refractivity: 56.1 cm³
Molar Volume: 156.6 cm³  
Density: 1.52 g/cm³
Flash Point: 240.4 °C
Index of Refraction: 1.634
Storage tempreture: -20 °C
Surface Tension: 50.4 dyne/cm
Enthalpy of Vaporization: 73.7 kJ/mol
Boiling Point of 1H-1,2,3-Triazole-4-carboxamide,1-[(2,6-difluorophenyl)methyl]- (CAS NO.106308-44-5): 473.8 °C at 760 mmHg
Vapour Pressure of 1H-1,2,3-Triazole-4-carboxamide,1-[(2,6-difluorophenyl)methyl]- (CAS NO.106308-44-5): 3.81E-09 mmHg at 25 °C
Canonical SMILES: C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F
InChI: InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)
InChIKey: POGQSBRIGCQNEG-UHFFFAOYSA-N

 1H-1,2,3-Triazole-4-carboxamide,1-[(2,6-difluorophenyl)methyl]- , its cas register number is 106308-44-5. It also can be called Rufinamide ; and 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide . Its classification code are Antiepileptic; Treatment of partial-onset seizures and Treatment of seizures in Lennox-Gastaut syndrome.